Companies
Jinyu Bio-technology
FMD and ASF vaccines — Cell-suspension culture.
- Country
- China
GMP
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsusda-aphisemaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | 1.255 billion yuan (2024-12-31) | file.finance.qq.com |
| Capacity | 2.7 billion mL of FMD vaccines annually | jinyubiotech.com |
| Capacity | 2 billion doses of FMD vaccines annually | jinyubiotech.com |
| Production site | Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang production bases | file.finance.qq.com |
| Production site | Research facility in Kansas, USA | pharmaceutical-technology.com |
| Certification | Veterinary GMP certification (2021) | static.sse.com.cn |
| Regulatory approval | 49 new veterinary drug registration certificates and 106 veterinary drug production approvals | static.sse.com.cn |
| Regulatory approval | Clinical trial approval for mRNA vaccine for feline infectious peritonitis (FIP) (2025-07-25) | news.futunn.com |
| Headquarters | Hohhot, Inner Mongolia, China | pharnexcloud.com |
Independent sources: file.finance.qq.com · news.futunn.com · pharmaceutical-technology.com · pharnexcloud.com · static.sse.com.cn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Veterinary biotech & mRNA veterinary drugs | livestock-aqua | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.